Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

Hepatology

Volumn 29, Issue 3, 1999, Pages 971-975

  Lin, Shi Ming ^a   Sheen, I Shyan ^a   Chien, Rong Nan ^a   Chu, Chia Ming ^a   Liaw, Yun Fan ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PLACEBO; PREDNISOLONE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA DETERMINATION; FOLLOW UP; HEPATITIS B; HUMAN; INCIDENCE; INFECTION RISK; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; STEROID BINDING; SURVIVAL RATE;

EID: 0033027690     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290312     Document Type: Article

References (12)

1. Collconi M, Buzzoni R, Bajetta E, Bochicchio AM, Bartoli C, Audisio R, Bonfanti G, et al. A phase II study of mitoxantrone combined with beta-interferon in unresectable hepatocellular carcinoma. Cancer 1993; 72:3196-3201.
2. Kardinal CG, Moertel CG, Wieand HS, Schutt AJ, O'Connel MJ, Wrislt K, Wiesenfeld M, et al. Combined doxorubicin and alpha interferon therapy of advanced hepatocellular carcinoma. Cancer 1993;71:2187-2190.
3. Sachs E, Di Bisceglie AM, Dusheiko GM, Song E, Lyons SI, Schoub BD, Kew MC, et al. Treatment of hepatocellular carcinoma with recombinant leukocyte interferon: pilot study. Br J Cancer 1985;52:105-109.
4. Liaw YE Current therapeutic trends in therapy for chronic viral hepatitis. J Gastroenterol Hepatol 1997;12(Suppl):346S-353S.
5. Wong DKH, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993:119:312-323.
6. Cohard M, Poynard T, Mathurin P, Zarski JP. Prednisone-interferon combination in the treatment of chronic hepatitis B: direct and indirect meta-analysis. HEPATOLOGY 1994;20:1390-1398.
7. Niederau C, Heintges T, Lange S, Goldmann G, Niederanu CM, Mohr L, Haussinger D, et al. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996;334:1422-1427.
8. Korenman J, Baker B, Waggoner J, Everhart JE, Di Bisceglie AM, Hoofnagle JH. Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med 1991;114:629-634.
9. Carreno V, Castillo I, Molina J, Porres JC, Bartolome J. Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy. J Hepatol 1992;15:102-106.
10. Lok ASF, Chung HT, Liu VWS, Ma OCK. Long-term follow-up of chronic hepatitis B patients treated with interferon alfa. Gastroenterology 1993;105:1833-1838.
11. Oon CG. Long-term survival following treatment of hepatocellular carcinoma in Singapore: evaluation of Wellferon in the prophylactics of high-risk pre-cancerous conditions. Cancer Chemother Pharmacol 1992;31 (Suppl):137S-142S.
12. Mazzella G, Accogli E, Sottili S, Festi D, Orsini M, Salzetta A, Novelli V, et al. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. J Hepatol 1996;24:141-147.